The Texas Department of Public Safety’s latest data for October 2023 provides an intriguing snapshot of the state’s healthcare landscape. These statistics unveil a nuanced perspective on patient and physician growth, as well as the current state of medical accessibility in the Lone Star State.

Patient Growth:
In October 2023, Texas witnessed an increase in registered patients, reaching a total of 68,611. This marks a notable 4% growth from the previous month, showcasing the state’s sustained momentum in healthcare utilization. Comparing this figure to the same month in the previous year, the patient count has surged by an impressive 76%, indicating a robust upward trend in healthcare engagement.

Physician Registration:
The state’s physician roster has also experienced growth, with 765 registered physicians documented in the latest data. This represents a steady 1% increase from the previous month, reflecting ongoing engagement and interest among healthcare professionals. Over the past year, the number of registered physicians has seen a substantial 19% growth, indicating positive trends in attracting and retaining medical practitioners.

Patient-to-Physician Ratio:
The patient-to-physician ratio currently stands at 90 patients per physician. This ratio has grown by 2% from the previous month, underscoring the increased demand for healthcare services. Over the past year, there has been a significant 48% growth in the patient-to-physician ratio, emphasizing the ongoing challenges in healthcare access and the importance of optimizing the distribution of medical resources.

Access to Medical Products:
A striking observation pertains to the limited access to medical products for the 68,611 registered patients. Presently, only three active companies facilitate access, with fewer than 30 locations available for patients who actively participate in the program. This highlights a significant gap in accessibility and emphasizes the pressing need for broader availability and increased options for patients to ensure comprehensive and effective healthcare delivery.

Relative Scale:
In a state as vast as Texas, boasting a population of 30,000,000, the 68,611 registered patients constitute only 0.22% of the total population. This statistic serves as a compelling reminder of the considerable potential for further expansion and development in the state’s medical program. The relatively low percentage underscores the opportunity to enhance outreach efforts, engage more residents, and address the healthcare needs of a larger portion of the population.

October 2023 data showcases positive trends in patient and physician growth, highlighting the need for ongoing efforts to enhance healthcare infrastructure, accessibility, and the availability of medical products in Texas.

Comparison with Florida Medical Market

Florida’s Growing Patient Count

At the end of 2022, Marijuana Policy Project (MPP) reported that Florida had 831,775 registered patients, making up 3.74% of the state’s population. This highlights the increasing acceptance of medical cannabis as a viable treatment option.

Extensive Dispensary Network

To cater to this demand, Florida has 501 active dispensaries, operated by 22 different companies. This shows the competitive nature of the industry and ensures patients have convenient access to their prescribed treatments.

Florida’s Medical Cannabis Program is thriving, with a significant patient count and a robust dispensary network, exemplifying the program’s success and the growing role of medical cannabis in the state’s healthcare landscape.

 

News on the latest application round

More than 130 applications have been submitted to the Texas Department of Public Safety for medical marijuana dispensaries, marking a significant response since the reopening of applications in January after a four-year hiatus.

Despite a recent bill to expand the state’s medical marijuana program stalling in the Senate, the DPS reports no current plans for usage law expansion, emphasizing their commitment to ensuring statewide access to low-THC cannabis for registered patients. For further details, visit KVUE.

 

 

Watch the TexMed APP launch video on YouTube

If you’re looking to stay in tune with the Texas Medical market, please check out TexMedCannabis.com

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Cannabis Delivery Services: Bringing Accessibility to Cannabis Enthusiasts Across the US

Legalizing cannabis in the United States has opened doors to new possibilities for consumers, but accessibility remains a concern for many. For some, reaching a dispensary can be challenging due to transportation limitations, health issues, or the need for childcare. In response to these challenges, cannabis delivery services have emerged as a godsend for those seeking a convenient and hassle-free way to access their favorite products.

Here is a map of all the cannabis stores in New Jersey 2023

The state of New Jersey has always been at the forefront of progressive changes, and with the legalization of recreational cannabis, it has taken another step towards pioneering new paths. As the Garden State embraces a budding industry, it is crucial for residents and entrepreneurs alike to understand the cannabis shop landscape in New Jersey.

Missouri Division of Cannabis Regulation Initiates Recall of 62,000 Cannabis Products: An In-Depth Look at the Delta Extraction Case and Industry Lessons

The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.

Newsletter